Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Purchase individual online access for 1 year to this journal.
Price: EUR 595.00Impact Factor 2024: 3.4
The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease.
The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease.
Authors: Adeli, Hojjat | Ghosh-Dastidar, Samanwoy | Dadmehr, Nahid
Article Type: Research Article
Abstract: Prediction or early-stage diagnosis of Alzheimer's disease (AD) requires a comprehensive understanding of the underlying mechanisms of the disease and its progression. Researchers in this area have approached the problem from multiple directions by attempting to develop (a) neurological (neurobiological and neurochemical) models, (b) analytical models for anatomical and functional brain images, (c) analytical feature extraction models for electroencephalograms (EEGs), (d) classification models for positive identification of AD, and (e) neural models of memory and memory impairment in AD. This article presents a state-of-the-art review of research performed on computational modeling of AD and its markers. The review covers the …following approaches: computer imaging, classification models, connectionist neural models, and biophysical neural models. It is concluded that a mixture of markers and a combination of novel computational techniques such as neural computing, chaos theory, and wavelets can increase the accuracy of algorithms for automated detection and diagnosis of AD. Show more
Keywords: Alzheimer's disease, EEG, imaging, biophysical, connectionist, neural models
DOI: 10.3233/JAD-2005-7301
Citation: Journal of Alzheimer's Disease, vol. 7, no. 3, pp. 187-199, 2005
Authors: Henriques, Ana Gabriela | Domingues, Sara C.T.S. | Fardilha, Margarida | da Cruz e Silva, Edgar F. | da Cruz e Silva, Odete A.B.
Article Type: Research Article
Abstract: Production of the amyloid β (Aβ) peptide via altered metabolism of the amyloid β-Protein Precursor (AβPP) appears to be a key event in the pathology of Alzheimer Disease (AD). Accordingly, altered processing of AβPP was observed under conditions of abnormal cellular stress induced by sodium azide in the presence of 2-deoxy-D-glucose (2DG). As previously reported, the production of sAβPP (the secreted fragment of AβPP) was inhibited. However, our data further suggests that 2DG alone can account for most of the observed effects on AβPP processing in COS-1 cells and PC12 cells. It appears that 2DG interferes with the normal glycosylation …of AβPP and its maturation process, having direct consequences on sAβPP production. Interestingly, PMA (phorbol 12-myristate 13-acetate)-induced sAβPP production was maintained under the stress conditions used, suggesting that potential non-amyloidogenic AβPP processing can still be favoured. This is of potential therapeutic interest, since it indicates that even under adverse stress conditions drugs such as PMA can affect AβPP processing, leading to increased sAβPP production and a concomitant reduction in Aβ production. However, the induction of sAβPP production was not identical when the phosphatase inhibitor OA (okadaic acid) was used. In fact, the typical OA-induced increase in sAβPP production could be abolished under specific conditions. This constitutes an interesting precedent for the possible dissociation of the PMA and OA responses in terms of sAβPP production. The involvement of protein phosphatases, which are inhibited by OA, in AβPP processing, was reinforced by the increased co-localization of AβPP and PP1α (protein phosphatase 1α) at the cell surface upon exposure to OA and PMA. Overall, our results support the notion that signal transduction processes may be of particular relevance for our understanding of the molecular basis of AD, and for the design of rational signal transduction therapeutics. Show more
Keywords: stress, phorbol ester, PP1, protein phosphatase 1
DOI: 10.3233/JAD-2005-7302
Citation: Journal of Alzheimer's Disease, vol. 7, no. 3, pp. 201-212, 2005
Authors: Puig, B. | Ferrer, I. | Ludueña, R.F. | Ávila, J.
Article Type: Research Article
Abstract: The expression of βI-, βII- and βIII-tubulin isotypes was examined by immunohistochemistry in the entorhinal and transentorhinal cortices, hippocampus and dentate gyrus in normal human brains and in cases with Alzheimer's disease (AD), Pick's disease (PiD) and in argyrophilic grain disease (AGD). The results showed that βII-tubulin predominated in the upper layers (mainly layer II) and βIII-tubulin in the inner layers of the entorhinal and transentorhinal cortices in control brains. βII-tubulin immunoreactivity was higher than βIII-tubulin immunoreactivity in granular neurons of the dentate gyrus, whereas pyramidal neurons of the hippocampus proper were stained equally with anti-βII-tubulin and βIII-tubulin antibodies. No …preferential layering distribution was observed for βI-tubulin. Polymerization assays with tubulin peptides following the method of microtubule-associated protein displacement demonstrated that the βI and βIII isotypes have a higher binding capacity for tau than does the βII isotype. Interestingly, about 60% of neurons with neurofibrillary tangles in layer II of the entorhinal and transentorhinal cortices in AD were selectively stained with anti-βII-tubulin antibodies. Moderate βII-tubulin immunoreactivity was also observed in Pick bodies in PiD. Taken together, these findings support the view that high βII-tubulin content is a contributing factor in the formation of abnormal hyper-phosphorylated tau aggregates. Show more
Keywords: Alzheimer's disease, Pick's disease, tubulin, tau
DOI: 10.3233/JAD-2005-7303
Citation: Journal of Alzheimer's Disease, vol. 7, no. 3, pp. 213-220, 2005
Authors: Fiala, Milan | Lin, Justin | Ringman, John | Kermani-Arab, Vali | Tsao, George | Patel, Amish | Lossinsky, Albert S. | Graves, Michael C. | Gustavson, Andrew | Sayre, James | Sofroni, Emanuela | Suarez, Tatiana | Chiappelli, Francesco | Bernard, George
Article Type: Research Article
Abstract: The defective clearance of amyloid-β (Aβ) in the brain of Alzheimer's disease (AD) patients is unexplained. The immunohistochemical studies of the frontal lobe and hippocampus show perivascular and intraplaque infiltration by blood-borne macrophages containing intracellular Aβ but only inefficient clearance of Aβ deposits. Neurons and neuronal nuclei, respectively, express interleukin-1β and the chemokine RANTES, which could induce the inflammatory cell infiltration. To clarify the pathophysiology of Aβ clearance, we examined Aβ phagocytosis by monocytes and macrophages isolated from the blood of age-matched patients and controls. Control monocytes display excellent differentiation into macrophages and intracellular phagocytosis of Aβ followed by Aβ …degradation or export. AD monocytes show poor differentiation and only surface uptake of Aβ and suffer apoptosis. HLA DR and cyclooxygenase-2 are abnormally expressed on neutrophils and monocytes of AD patients. AD patients have higher levels of intracellular cytokines compared to controls. Thus Aβ clearance is not restricted to brain microglia and involves systemic innate immune responses. In AD, however, macrophage phagocytosis is defective, which may elicit compensatory response by the adaptive immune system. Show more
Keywords: macrophage/monocyte, amyloid-beta phagocytosis, macrophage apoptosis, innate immunity, inflammation and Alzheimer's disease
DOI: 10.3233/JAD-2005-7304
Citation: Journal of Alzheimer's Disease, vol. 7, no. 3, pp. 221-232, 2005
Authors: Ashford, J. Wesson | Crutcher, Keith A. | Robinson, Stephen R. | Smith, Mark A.
Article Type: Editorial
DOI: 10.3233/JAD-2005-7305
Citation: Journal of Alzheimer's Disease, vol. 7, no. 3, pp. 233-233, 2005
Authors: Morris, John C. | Cummings, Jeffrey
Article Type: Case Report
DOI: 10.3233/JAD-2005-7306
Citation: Journal of Alzheimer's Disease, vol. 7, no. 3, pp. 235-239, 2005
Authors: Petersen, Ronald C. | Bennett, David
Article Type: Case Report
DOI: 10.3233/JAD-2005-7307
Citation: Journal of Alzheimer's Disease, vol. 7, no. 3, pp. 241-245, 2005
Authors: Ashford, J. Wesson | Atwood, Craig S. | Blass, John P. | Bowen, Richard L. | Finch, Caleb E. | Iqbal, Khalid | Joseph, James A. | Perry, George
Article Type: Case Report
DOI: 10.3233/JAD-2005-7308
Citation: Journal of Alzheimer's Disease, vol. 7, no. 3, pp. 247-253, 2005
Article Type: Discussion
DOI: 10.3233/JAD-2005-7309
Citation: Journal of Alzheimer's Disease, vol. 7, no. 3, pp. 255-262, 2005
Article Type: Announcement
DOI: 10.3233/JAD-2005-7310
Citation: Journal of Alzheimer's Disease, vol. 7, no. 3, pp. 263-265, 2005
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]